Manulife Financial (MFC.TO)

Debating quality of company within investment team. Sees money coming out of financial sector in Canada - going into insurance companies. Not overly positive on direction of business. If expectations for rate cuts continues - will be good for business. Would recommend investors to hold the position. 

Transformed itself, market's recognizing that. Can confidently buy now. Pretty competitive, safe dividend yield, around 5%. Taken steps to pivot business away from riskier liabilities. Still trades at a discount.

The moving averages are trending higher and up a new leg higher. Has great exposure to a fast-growing Asian market. Pays a 4.9% dividend and cheap at 1.5x price-to-book.

Their big product was guaranteeing a life insurance policy on stock returns. So, when the market melted down, there was a big scare. Now, the market has come back, and those policies won't lose as much. MFC used to be held up by a fortress balance sheet. 15 years later, they've grown into that balance sheet. Saw nice earnings growth in 2023 and expects it also for 2024.

Business headed in right direction. Profitability increasing, return on equity also strong. New management has turned things around. Current yield ~5% is very stable. Interest rates not a concern - have weather rising rates well. Would continue to buy - still owns shares. 

MFC is the name in the Insurance space that keeps working. A few years ago, it was like that cough syrup -- doesn't taste good, but it works. Insurance companies are set to outperform banks. MFC is #1, SLF #2, POW #3.

Share price up nicely - a little strong, but overall very good trends.. Excellent balance sheet strength. Capital allocation very strong the past few years. Excellent CEO. Recently selling problematic assets. Seeing rebound in Asia market. Good for shareholders in the long term. Core holding in income portfolio. 

Ranks a bit higher than SLF on his screens, but it's not by a significant amount. Exposure to Asia, a growing market. Yield is 4.9%, dividend should increase over time.

Some of the insurers are outperforming the banks because they're a bit more levered to falling interest rates, fewer credit concerns and loan-loss provisions. Likes banks, too.

At best - under performer. Not the best option for investors. More Asia exposure than North America. Would prefer Sun Life. Not a good investment for long term. Don't buy. 

Banks are a tougher story due to capital ratios and inability to grow. Instead of a bank, look to MFC or SLF.

Stock performance a good sign for momentum investors. Resistance in share price appears to have ebbed. Would recommenced buying based on seasonal basis. 

Excellent franchise with highest credit ratings in the world. Very good debt levels. New CEO performing very well. Last year saw dividend increase. Higher interest rates mean better returns for the business. Will continue to own shares. 

Breaking out of a more than decade-long range. Finally have some fundamentals on LTC portfolio. Reinsurance deal was better than expected. Underlying business performing pretty well. Asia has both potential and potential risks. Not expensive. Have to see if the big institutional money moves in. Yield is 5.05%.

It's popped slightly recently. They just did a deal in which they released $1.2 billion of free capital--this finally woke up people that MFC is a little undervalued. It still is at 8x PE with a price-to-book of 1.3x. Under this CEO in recent years, they've been streamlining operations to be more efficient and adding growth. This has been a top pick of his many times.

Widely held. Had been stuck in a trading range for years. However, finally breaking out. Last week's transaction has prompted a look with fresh eyes. De-risked US business, prompting stock re-rating. Warming up to it, might pull the trigger in the new year.